DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Mustargen (Mechlorethamine) - Breast Cancer in Situ - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Breast Cancer in Situ (1)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Mustargen (Mechlorethamine) where reactions include breast cancer in situ. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Mustargen side effects in 42 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-31

Patient: 42 year old female

Reactions: Atrial Septal Defect, Fatigue, Hypoxia, Breast Cancer in Situ, Fibrosis, Exercise Tolerance Decreased

Drug(s) suspected as cause:
Mustargen

Other drugs received by patient: Thyroid TAB; Lexapro (Escitalopram Ocalate); Calcium / Vitamin D (Lekovit CA); Levothyroxine Sodium

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017